- Academic Editors
-
-
-
†These authors contributed equally.
Background: Patients with non-ST-elevation acute coronary syndrome
(NSTE-ACS) consists of a heterogenic population and improvement in identification
of a specific risk profile is needed. In this study we aimed to obtain better
insight in the role of different biomarkers for patients undergoing a routine
invasive diagnostic strategy within 24 hours after admission. Methods:
An Immediate or Early Invasive Strategy in Non-ST-Elevation Acute Coronary Syndrome
(OPTIMA-2) study was a randomized controlled prospective open-label multicentre
trial, randomizing NSTE-ACS patients. An invasive strategy was either immediate
(